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Atherosclerosis is composed of cellular and acellular
elements that combine to form a variety of plaque
types (Table 1, Fig. 1). With respect to atheroscler-
osis imaging, four plaque histologic characteristics are
considered in this Task Force report: necrotic core,
fibrous cap, calcium, and inflammatory activity. The
relative prevalence of these components depends on
the degree of stenosis, the clinical coronary heart dis-
ease syndrome, and nonlocal factors including the pa-
tient’s gender and traditional and nontraditional risk
factors.
COMPONENTS OF ATHEROSCLEROSIS THAT
FORM TARGETS FOR ATHEROSCLEROSIS IMAGING
Several studies (1–4) have reported the relationship between
the following types of plaque components and degree of
stenosis.
Necrotic core. A necrotic core is present in approxi-
mately 25% of plaques with less than 50% cross-sectional
stenosis, and this increases in prevalence with increasing
stenosis severity. Above 70% cross-sectional luminal
narrowing, about 75% of plaques will demonstrate a
necrotic core.
Fibrous cap. Fibrous cap atheromas are defined as
plaques with a well-defined lipid core covered by a
fibrous cap, which may be relatively acellular (made
of dense collagen) or may be rich in smooth cells. No
data in autopsy studies are available regarding the
prevalence of fibrous caps of various thickness. Sten-
osis severity is directly related to the proportion of
dense fibrous tissue (type I collagen) in the fibrous cap,
and inversely related to smooth-muscle-cell–rich areas
(2– 4).
Calcium. The presence of calcium is strongly correlated
with stenosis severity (3–6) (Fig. 2) and is modulated by
age. As age advances, the mean percent calcified area
increases both for plaques with moderate (greater than or
equal to 50% to less than 75% cross-sectional area) luminal
narrowing and severe (75% to 90% cross-sectional luminal
area) narrowing (5). Importantly, a thrombotic, recanalized
total occlusion may be devoid of calcification. The incidence
of calcification in total occlusions may be partly a function of
lesion age (7).
Inflammatory activity. Inflammation, both of the intima
and adventitia, increases in prevalence with increasing
percent stenosis (1).
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GENERAL ISSUES RELATED TO
DETECTION OF PLAQUE
COMPONENTS BY ATHEROSCLEROSIS IMAGING
Should the anatomic targets we image vary by the type of
future events under consideration? Detection of lipid-
rich lesions is likely more important in screening individuals
for their risk of myocardial infarction (MI) than it is for
screening for sudden coronary death risk (Fig. 3) (1–4). The
composition of plaques in patients dying with acute MI
reflects a larger proportion of lipid, as compared to those
plaques of patients dying suddenly. These findings are
corroborated by quantitation of atheromas and thin-cap
atheromas in various coronary syndromes (see below). The
preponderance of data for calcium does not suggest signif-
icant differences in coronary syndromes when plaque burden
is factored.
Autopsy and atherectomy studies have compared compo-
nents of plaque across groups of patients dying with stable
angina, unstable angina, acute MI, and sudden death. In
stable angina, the culprit plaque consists of either a lipid-
rich fibrous tissue (40%) or is a predominantly pure fibrous
lesion (60%) in plaques causing greater than 75% cross-
sectional luminal narrowing (8). Atherosclerotic plaques
from unstable angina patients are more cellular than plaques
from patients with stable angina, resembling plaques re-
moved from patients with restenosis lesions (9). In unstable
angina and MI, the plaque area occupied by macrophages
and the number of T-lymphocytes within the plaque are
significantly greater than in plaques from stable angina
patients, and activation of these cells, as shown by
HLA-DR expression, is increased (10–12).
The likelihood and size of a necrotic core is greatest in
plaques with moderate or worse stenosis severity (Fig. 4)
(3,4). Baroldi et al. (1) demonstrated that plaques causing
moderate luminal narrowing (less than 70% cross-sectional
area narrowing) are more likely to have necrotic cores in
patients dying with acute MI (56%) than those dying
suddenly with chronic ischemia, sudden death, or accidental
causes (30% to 40%). The same invesigators showed that
calcium and inflammation are most prevalent in moderately
and severely narrowed vessels of patients dying with acute
MI, moderately prevalent in chronic ischemic syndromes
and sudden coronary death, and least prevalent in accidental
deaths. In contrast, Kragel et al. (3) showed that the percent
calcium area within the intima of severely narrowed arteries
was actually greater in sudden death (approximately 16%) as
compared to unstable angina and acute MI (8% to 10%).
Autopsy data from the Armed Forces Institute of Pathology
(unpublished data) showed similar coronary calcification in
patients dying from coronary disease, as compared to those
dying of noncoronary causes. In this study, after adjustment
for overall plaque burden, gender, and age, there was a lesser
Table 1. Atherosclerotic Plaque Classifications
Traditional
Classification Stary et al. (34,76)
Virmani et al. (32)
Initial Progression
Early plaques Type I: microscopic detection of lipid
droplets in intima and small groups of
macrophage foam cells
Intimal thickening None
Fatty streak Type II: fatty streaks visible on gross
inspection, layers of foam cells,
occasional lymphocytes and mast cells
Intimal xanthoma None
Type III (intermediate): extracellular
lipid pools present among layers of
smooth muscle cells
Pathologic intimal thickening Thrombus (Erosion)
Intermediate
plaque
Atheroma Type IV: well-defined lipid core; may
develop surface disruption (fissure)
Fibrous-cap atheroma Thrombus (Erosion)‡
Late lesions Thin fibrous-cap atheroma Thrombus (Rupture)
Hemorrhage/fibrin§
Type Va: new fibrous tissue overlying
lipid core (multilayered
fibroatheroma)*
Healed plaque rupture, erosion Repeated rupture or
erosion with or
without total
occlusion
Type Vb: calcification† Fibrocalcific plaque (with or
without necrotic core)
Fibrous plaque Type Vc: fibrotic lesion with minimal
lipid (could be result of organized
thrombi)
Miscellaneous/ Complicated/advanced Type VIa: surface disruption Calcified nodule Thrombus (usually
complicated plaques Type VIb: intraplaque hemorrhage nonocclusive)
features Type VIc: thrombosis
*May overlap with healed plaque ruptures; †Occasionally referred to as type VII lesion; ‡May further progress with healing (healed erosion); §May further progress with healing
(healed rupture).
1875JACC Vol. 41, No. 11, 2003 Burke and Virmani et al.
June 4, 2003:1855–917 Task Force #2—Pathologic Basis for New Atherosclerosis Imaging Techniques
Figure 1. Histopathology of plaque progression. Descriptions begin at top, from left to right. Intimal thickening is normal in all age groups and is characterized by smooth muscle cell accumulation within
the intima. Intimal xanthoma corresponds to the fatty streak and denotes the accumulation of macrophages and lymphocytes within the intimal thickening lesion. Pathologic intimal thickening denotes the
accumulation of extracellular lipid. Fibrous cap atheroma indicates the presence of a necrotic core under a fibrous cap, which may become thinned (thin-cap atheroma). This lesion may rupture, with exposure
of thrombus to the lumen. The thrombus of a plaque erosion may overlie pathologic intimal thickening (left) or fibrous cap atheroma (right). Calcified nodule is a rare form of coronary thrombus. Acute rupture
may progress to healing (healed plaque rupture) without luminal occlusion. EL  extracellular lipid; NC  necrotic core; FC  fibrous cap; Th  thrombus.
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degree of calcification in patients dying with sudden coro-
nary death, as compared to those dying of other causes.
Could regional variability in atherosclerosis (e.g., coro-
nary vs. peripheral) influence the accuracy of certain
modalities/pathologic targets for CHD prediction? Few
anatomic studies have compared, in individual patients, the
composition of plaques from different arterial beds. A recent
autopsy study by Vink et al. (13) demonstrated that, in
elderly patients (age 82 10 years), the coronary circulation
had the greatest luminal narrowing, followed by the internal
iliac arteries, femoral arteries, abdominal aorta, common
iliac arteries, common carotid arteries, radial arteries, renal
arteries, brachial arteries, superior mesenteric arteries, ex-
ternal iliac arteries, ascending aorta, middle cerebral arteries,
basilar arteries, internal carotid arteries, anterior cerebral
arteries, and posterior cerebral arteries. The extent of
lipid-rich regions (determined by absence of collagen stain-
ing with picrosirius red) was greatest in the carotid arteries,
followed by the coronary, brachial, and iliac arteries. No
data are available that evaluate lipid rich necrotic core in
individual patients across arterial beds.
In comparison to coronary artery plaques, corrected for
degree of cross sectional area luminal narrowing, carotid
plaques are more likely to have intraplaque hemorrhage, acute
plaque ruptures, and thin caps (14,15). After rupture, carotid
plaques are more likely to ulcerate as compared to coronary
plaques. When the infiltrate of macrophages is analyzed,
carotid plaques have fewer cap macrophages at the site of
rupture than do coronary plaques. In general, calcification of
carotid plaques is similar to that of coronary plaques, although
calcification is more likely in the carotid to begin at the luminal
surface, resulting in eruption of calcific nodules.
Targeting lesions: culprits versus generalized atheroscle-
rosis interrogations: do we need to target the culprit
plaque? “Vulnerable plaque,” a term coined by Little in
1990 (16) and further defined by Muller in 1992 (17), refers
to a lesion prone to thrombosis. If atherosclerosis were a
gradually, linearly progressive diffuse disease, the most
important task of imaging would be to determine overall
plaque burden. However, it has been shown that sudden
thrombotic occlusion often occurs in areas of only moderate
pre-existing atherosclerosis, and that plaque progression
occurs largely as a result of episodic thrombosis and orga-
nization. Serial angiographic and necropsy studies have
shown that the risk of plaque rupture correlates only weakly
with the degree of stenosis (18). However, coronary artery
disease is generally widespread in patients with acute coro-
nary syndromes. Estimates of overall plaque burden (for
example, composite calcium scores using computed tomog-
raphy) are predictive of future acute events (19), and autopsy
studies of sudden coronary death have shown diffuse disease
in a majority of cases. Guthrie et al. (20) demonstrated that
Figure 2. Histomorphometric study demonstrating the percent cross-
sectional luminal narrowing is positively correlated with the presence of any
calcification. Burke AP, et al. Pathophysiology of Calcium Deposition in
Coronary Arteries. HERZ 2001;26:239–44. (Copyright Urban & Vogel.
Reproduced with permission.)
Figure 3. Histomorphometric data demonstrate that, with increasing
stenosis, necrotic core increases, especially in patients with acute myocar-
dial infarction (3,4).
Figure 4. Thin-cap atheromas are most frequent in patients dying with
acute myocardial infarction (MI), followed by sudden coronary death
(SCD) victims and incidental disease. Fibroatheromas and thin cap
atheromas are not common in patients dying with plaque erosion (32).
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Figure 5. The distribution frequency of plaque ruptures (A,B) and thin-cap atheromas (C,D) by size of lipid core or lipid core as a percent of plaque area (x). The majority of plaque ruptures occur when
lipid core area forms 25% to 50% of plaque area, or 1 to 3 mm2 lipid core area. In the case of thin-cap atheromas, the degree of cross-sectional area luminal narrowing and area of necrotic core is shifted to
the left (lesser or smaller) as compared to plaque ruptures. Data derived from sudden death registry, Armed Forces Institute of Pathology (32).
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nearly 75% of patients dying with angina or MI demonstrate
vessel disease of three or more vessels. Data from autopsies
indicate that the number of affected vessels in patients dying
with severe coronary artery disease is lowest in patients
dying with plaque erosion, intermediate in patients dying
with plaque rupture, and highest in patients dying with
stable plaque and healed MI (21). However, the degree of
overall plaque burden varies tremendously in sudden coro-
nary death. The overall plaque burden increases in patients
dying with severe coronary disease as age advances. There-
fore, the identification of “vulnerable plaques” is of special
importance in younger individuals.
Plaque erosions versus plaque rupture. The nature of
plaque disruption underlying coronary thrombosis is heter-
ogeneous. It has recently been reported that thrombi in
sudden coronary death may occur from two distinctly
different plaque morphologies. One is plaque rupture, ac-
counting for 60% of thrombi, and the other is plaque
erosion, accounting for the remaining 40% in young
victims of sudden coronary death (22). However, plaque
ruptures are several times more common in the elderly
than plaque erosion. For example, in the fifth decade, the
estimated rate of fatal rupture was for men 17 per
100,000 per year, compared to 6 per 100,000 per year for
erosions (23). The relative incidence of plaque rupture
and plaque erosion is similar in different clinical coronary
heart disease syndromes—for example MI and sudden
death (24,25). Histologically, plaque erosions are much
less frequently calcified (23% vs. 69% of plaque ruptures)
and more often occur with nonocclusive thrombi and
eccentric plaques (82% vs. 57%, p0.08; 82% vs. 54%, p
 0.07, respectively) (22).
Smoking is associated with atherothrombosis and is
related either to erosion or rupture (21). In autopsy studies,
75% of normotensives dying with severe coronary athero-
sclerosis demonstrate acute thrombi. In comparison, only
36% of hypertensives dying suddenly with severe coronary
disease demonstrate acute thrombi, with the remainder
demonstrating stable plaque, with either healed infarct or
cardiomegaly (48%) or stable plaque with severe narrowing
in the absence of infarction, thrombus, or cardiomegaly
(16%) (26). These results demonstrate that identifying a
plaque prone to thrombosis will predict the majority of
acute infarcts and sudden deaths in normotensives, and only
about one-third of sudden deaths in hypertensives.
The relationship between risk factors and culprit plaque
morphology is similar in women and men (27). The
proportion of women dying suddenly with plaque erosion is
higher than in men, especially in those dying under age 50
years. In general, the coronary plaques of women have been
shown to be more cellular than those of men (28,29).
Plaques of premenopausal women demonstrate relatively
little necrotic core and calcification in comparison to both
men and to postmenopausal women, probably because of
the relatively high rate of plaque erosion in young women,
and because of the protective effect of estrogen on the
formation of large necrotic cores (30).
CONSIDERATIONS OF
INDIVIDUAL PLAQUE COMPONENTS
Necrotic core. DOES SIZE OF THE NECROTIC CORE MAT-
TER AND SHOULD IT BE EVALUATED WITH ATHEROSCLE-
ROSIS IMAGING? Data from the laboratory of W.C. Roberts
showed that the infarct-related artery at the site of rupture
had much larger atheromatous cores as compared to plaques
with intact plaque (3,4,31), supporting the concept that a
large lipid core is associated with plaque vulnerability and
MI. Virmani et al. (32) have corroborated these data in
coronary arteries (Table 2) showing that mean necrotic core
size, independent of cross-sectional luminal narrowing, was
greatest in plaque ruptures, followed by thin-cap atheromas
and fibrous cap atheromas. Eighty percent of ruptured
plaques contained necrotic cores larger than 1.0 mm2 and,
in nearly 90%, lipid core comprised greater than 10% of the
plaque area (Fig. 5). The length of necrotic cores underlying
fatal and nonfatal plaque ruptures was found to average 9
mm, with a range of 3.5 mm to 22 mm (33).
Because of the a wide variation of necrotic core size in
relation to rupture, it is difficult to assign specific parameters
as cut-points for coronary heart disease (CHD) risk predic-
tion. For example, it is unknown if plaque rupture, either
fatal or nonfatal, occlusive or nonocclusive, occurs over the
largest necrotic core in a patient, or if local inflammatory,
hemodynamic, or other factors are more important. Based
on data such as that shown in Table 2, a plaque with a core
shorter than 3 mm, with an area of less than 1.0 mm2 (34),
and with a percent core of less than 10% appears to be
unlikely to rupture.
CHEMICAL COMPOSITION OF NECROTIC CORE. Although
the chemical composition of necrotic core may not be
currently relevant to imaging techniques, newer techniques
are being developed to take advantage of pH and temper-
ature changes. Also, magnetic resonance imaging and in-
Table 2. Approximate Sizes of Necrotic Core, in Fibroatheroma, Thin-Cap Atheroma, and
Acute Rupture (32)
Dimension
Plaque Type
Fibrous-Cap Atheroma Thin-Cap Atheroma Acute Plaque Rupture
Length, mm, mean/range 6 mm (range 1–18 mm) 8 mm (range 2–17 mm) 9 mm (range 2.5–22)
Necrotic core area, mm2 1.2  2.2 1.7  1.1 3.8  5.5
% Necrotic core area 15%  20% 23%  17% 34%  17%
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frared scanning utilize biochemical properties of plaques.
Early lipid pools (type II lesions) are composed primarily of
cholesterol esters (77%), with minor components of free
cholesterol and phospholipid. The increase and confluence
of separate extracellular lipid pools along with macrophage
breakdown result in late necrotic cores, with a lowering of
the melting point, and an increase in free cholesterol, fatty
acid, sphingomyelin, lysolecithin, and triglyceride (35,36).
Because only later cores are prone to rupture, the biochem-
ical differences between early and late necrotic core may be
relevant to plaque vulnerability. Felton et al. (37), using
aortic samples, have shown that disrupted plaques have
high-free cholesterol content in the center, with a low-free
to esterified cholesterol ratio at the edges, relative to intact
plaques, possibly because of macrophage breakdown and
active inflammation.
Fibrous cap. FREQUENCY AND DISTRIBUTION IN SUDDEN
CORONARY DEATH. Both the frequency and the distribu-
tion of fibrous-cap atheromas in the various coronary
syndromes vary with risk factor profile, age, and gender.
The proportional distribution of different plaque types is
inherently variable within individual patients because of the
continuous, evolutionary nature of atheroma formation.
This progression is modified by changes in cardiovascular
risk factors such as statin-mediated cholesterol lowering.
Fibrous cap atheromas are most frequent in patients dying
with acute MI or acute plaque rupture, followed by those
dying with stable plaque, other incidental causes of death,
and lastly plaque erosion (38). In the same study, the
coronary distribution of fibrous-cap atheromas was similar
to those of thin cap atheromas (39) and plaque ruptures,
with 60% occurring in proximal segments, 30% in mid-
arterial segments, and 10% in distal segments.
PATHOPHYSIOLOGY OF THE FIBROUS CAP. Because of the
small size of fibrous caps, it has been difficult to develop
tensometers to measure physical characteristics of lesions
(40). Pressures required to rupture balloon-induced plaques
in rabbit aortas are lower in lipid-rich plaques of
cholesterol-fed animals than in standard chow-fed animals
(41), supporting the connection between increased lipid
content and plaque instability (42). Large-strain, finite-
element analysis has shown that fibrous tissue and calcifi-
cation decreases plaque stress, whereas lipid pools increase
stress (43). Because the mechanical strength of arterial tissue
depends mostly on the integrity of its collagen scaffold,
potential changes that affect plaque collagen have been
investigated in relation to vulnerability. Interestingly, colla-
gen is, by mass, the most abundant component of advanced
atheroma (1,3,4). However, cap stability may be predicted
by the local variations in the distribution of collagen, as
development of transverse gradients was found in disrupted
caps and may be a critical aspect of vulnerability. Comput-
erized reconstructions of simulated and histologic sections
of real plaques suggest that stress may be concentrated at
critical points in the cap, and that computed high-stress
points in the shoulder region of the cap correlate with sites
of rupture found at autopsy (44,45).
RELEVANCE OF THE FIBROUS CAP FOR ATHEROSCLEROSIS
IMAGING. A common mechanism of disruption of the
fibrous cap atheroma occurs via the thinning and weakening
of the fibrous cap, resulting in breaks exposing tissue factor
and with subsequent thrombosis and vasospasm. A fibrous
cap has been defined as thin when it is less than 65 microns
in its minimum thickness. This is based upon a study
showing that the thickness of the fibrous cap in most (95%)
acute plaque ruptures was less than this (21). Kolodgie et al.
(39) demonstrated that the mean numbers of thin cap
atheromas, as so defined, was greater than or equal to 1.5 in
patients dying with acute MI and/or acute plaque rupture,
between 1 and 1.4 (mean 1.1  1.3) in patients dying with
stable plaque, and least common in patients without acute
rupture (0.9  1.2), healed rupture (0.5  0.8), or plaque
erosion (0.2  0.5). Thin-cap atheromas are more frequent
in men dying with acute MI and sudden death. Their
distribution in the coronary tree mirrors that of acute plaque
rupture. The mean necrotic core size and core length of
thin-cap atheromas are, however, smaller than in plaques
that rupture, and not significantly greater than fibrous cap
atheromas with a thicker cap (32) (Table 2).
THICKNESS OF THE FIBROUS CAP: RESOLUTION REQUIRED
FOR IMAGING OF CHD RISK. Because the range of fibrous
cap thickness in plaque rupture ranges from several microns
to approximately 150 microns, with the majority being
under 65 microns, at least in the coronary arteries, the
resolution of imaging techniques should be at the level of 50
microns or better, in order to identify 50 microns caps
(prone to rupture), 100 microns plaques (low risk), and over
150 microns (minimal risk). If fibrous cap is to be the only
mechanism for identifying thin cap atheromas, then char-
acterization of a plaque to the nearest 50 microns in
thickness would be necessary to construct a clinical classifi-
cation of plaques prone to rupture.
COMPENSATORY REMODELING: IS THIS A MARKER OF FI-
BROUS CAP INSTABILITY? Several studies, including autopsy
and ultrasound investigations, have demonstrated that out-
ward or positive coronary artery remodeling is more fre-
quent in areas of unstable plaques (25,46–49). After adjust-
ing for plaque area and measuring against proximal
reference segments, acute plaque ruptures, plaques with
large necrotic cores, especially those with intraplaque hem-
orrhage, and plaques rich in macrophages show expansion of
the internal elastic lamina (46). These data indicate that one
measure of plaque instability may be in identifying areas of
positive remodeling. Unfortunately, as is the case with other
indicators, remodeling should be a poor predictor of plaque
erosion, as, if anything, eroded plaques are found in seg-
ments with little or no remodeling, or even contraction of
the internal elastic lamina.
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PLAQUE CALCIFICATION
Calcification is prevalent in atherosclerotic plaques, and it
forms the basis for radiographic methods of plaque burden
screening. The earliest calcified elements are derived from
apoptotic smooth muscle cells, which form membrane-
bound matrix vesicles that actively calcify (50). These
microcalcifications are not detected by standard imaging
techniques, are readily identified in histologic sections only
by stains for calcium such as von Kossa’s stain, and are
present in the majority of early cores and areas of extracel-
lular lipid. With coalescence of microscopic calcium depos-
its, larger granules and plates of calcium form that may be
visualized by standard imaging techniques. Such radio-
graphically detectable calcification is present in the majority
of plaques with severe stenosis (6), and is influenced by a
variety of systemic and local factors. In an autopsy study of
men dying with severe coronary disease, radiographic cor-
onary calcification was present in 46% of men and women
under age 40 years, 79% of men and women age 40 to 49
years, 90% of men and women age 50 to 60, and 100% of
men and women older than 60. For women, the degree of
calcification showed a 10-year lag compared to that of men,
with equalization by the eighth decade.
RELATIONSHIP OF CALCIUM TO PLAQUE BURDEN: VALIDITY
AS AN ATHEROSCLEROSIS SURROGATE. There is an excel-
lent correlation between the extent of coronary calcification
and overall plaque burden. Simons et al. (51) in a series of
autopsy hearts, concluded that the detection of coronary
calcification by ultrafast computed tomographic scanning is
highly predictive of the presence of coronary atherosclerosis,
and, as had been shown by Mautner et al. (6) is almost
always present in a large segment or artery with obstructive
disease. However, the correlation in an individual segment
was somewhat limited, and total occlusions may be devoid
of calcium. Other autopsy studies have shown a good
correlation between calcified area and plaque burden (plaque
size), a significant but weak correlation between calcified
area and percent stenosis, and no correlation with lumen
size in a given segment (5,52). These studies suggest that
calcium imaging will provide a general indication of plaque
burden, but will not be helpful in detecting areas of maximal
stenosis in a given heart.
Patients with diffuse vascular calcification due to end
stage renal disease or other metabolic disturbances may have
marked, diffuse coronary calcification without significant
luminal narrowing. Further radiographic and histologic
characterization of such calcifications are needed accurately
distinguish them from potential destabilizing nodular cal-
cifications as described by Virmani et al. (32).
IS THERE INFORMATION TO BE GLEANED FROM THE PAT-
TERN OF CALCIFICATION, OR IS TOTAL CALCIUM BURDEN
THE ONLY RELEVANT VARIABLE? Postmortem radiographs
of coronary artery segments with morphologically deter-
mined plaques have indicated a wide range of plaque types
present at segments, showing a specific pattern of calcifica-
tion (5) (Fig. 6). Plaque erosions were exclusively present in
areas with stippled or no calcification. Plaque ruptures were
most frequently seen in areas of speckled calcification, but
were also present in fragmented or diffuse calcification.
Curiously, no ruptures were seen in segments devoid of any
calcification. Thin-capped atheromas were most frequently
present in areas of speckled calcification, but were also seen
in heavily calcified or uncalcified areas, suggesting that
calcification pattern is not helpful in diagnosing these
lesions. Healed ruptures are almost always seen in areas of
calcification, and most frequently in diffusely calcified areas
(5). Thus, in conjunction with other imaging modalities
that recognize lipid core size, it is possible that the presence
of irregular, mild to moderate calcification may aid in the
detection of plaques particularly prone to rupture. In a
plaque without a significant necrotic core, smooth muscle
cells may calcify as a plate or solid mass, with little
inflammatory activity in the form of macrophage infiltration
or successive ruptures. However, multiple healed ruptures
are typically accompanied by areas of irregular calcium
deposits, possibly initiated by a series of intraplaque hem-
orrhages and organization.
IS CALCIUM A DESIRABLE OR UNDESIRABLE COMPONENT
OF PLAQUES? There is an ongoing debate as to the effect of
calcification on “stability” of plaques: Does calcification
render a plaque more prone to rupture or is it a marker of
plaque quiescence? Biomechanical studies based on com-
puter models have suggested, as stated above, that calcium
may impart stability to the atherosclerotic plaque (43).
Several limitations must be considered within these issues.
Pathology studies have shown that nearly 25% of acute plaque
ruptures occur in areas of dense calcification. In addition, the
debate about calcification overlooks thrombi arising in the
absence of plaque disruption (i.e., plaque erosions, which have
typically little or no calcium). Finally, plaque calcification has
been associated with positive remodeling (46), probably as a
function of inflammation, which is desirable in the sense of
maintaining plaque lumen, but potentially undesirable in that
remodeling is a marker of plaque activity.
Genetic variability in tissue calcification. Tomo-
graphically or radiographically detectable calcification is
not present in all patients with severe coronary artery
disease and coronary heart disease risk factors, but it is a
function of age, renal function, vitamin D levels, and other
aspects of bone metabolism (53), the insertion/deletion
(I/D) polymorphism for angiotensin-converting enzyme
(54), and diabetes in women (5). Genetic variations in matrix
inhibitory proteins such as matrix gla protein likely play a
role in the degree of atherosclerotic plaque calcification in
the coronary arteries (55), and polymorphisms for tumor
necrosis factor, and inflammatory cytokines, may also influ-
ence coronary artery calcification (56). It has been estimated
that a large proportion of variation in coronary artery
calcification is not due to traditional risk factors (57), and
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genetic linkage studies have pointed to chromosome 6p21.3
(58). One could foresee the crude total calcium score eventually
replaced with one weighted for calcium distribution in the
coronary arteries, other metabolic markers, and genetic profiles
in order to more accurately predict risk of coronary events.
INFLAMMATORY ACTIVITY
Is inflammation a marker of plaque bioactivity? Inflam-
mation in coronary and aortic plaques has long been
associated with plaque “instability” (37,59–61). The rela-
tionship between inflammation and acute coronary syn-
dromes has been highlighted by recent correlations between
markers of systemic inflammation, especially C-reactive
protein, and CHD (62). Relevant to potential imaging for
inflammatory components, it is evident that inflammation in
atherosclerotic plaques is heterogeneous, consisting of various
cells types (including monocytes, macrophages, T-cells, B-cells
(63), neutrophils, and mast cells) and occurring in various sites
of the plaque, including the adventitia, shoulder region of the
atheroma, and within the fibrous cap.
Most ruptured plaques are characterized by a large pool of
lipid within the necrotic debris and a thin fibrous cap with
a dense infiltration of macrophages. The nature of the
inflammatory infiltrate within the cap region has been
extensively studied. The release of matrix-digesting en-
zymes by these cells is believed to contribute to plaque
rupture. Also, experimental evidence shows that macro-
phage myeloperoxidase (MPO) may be responsible for the
disruption of the fibrous cap in plaque rupture (64) and that
MPO-containing macrophages within the mural thrombus
may be associated with occlusive acute plaque ruptures (33).
Subsets of macrophages rich in myeloperoxidase are present
in the fibrous cap and constitute approximately 13% of the
total population at sites of rupture (33). Some evidence that
there is more thermal heterogeneity in plaques from patients
with unstable angina and acute MI, than in plaques from
patients with stable angina (65). Thus, imaging techniques
that are able to detect enzymatic pathways that alter
temperate or pH have the potential, yet unproven, to
identify incipient plaque rupture.
Figure 6. Relationship between plaque morphology and radiographic calcification, autopsy arteries. Reproduced with permission. Burke AP, et al.
Pathophysiology of Calcium Deposition in Coronary Arteries. HERZ 2001;26:239–44. (Copyright Urban & Vogel. Reproduced with permission.)
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Prevalence and distribution of inflammatory cells. Inflam-
matory cells, in particular macrophages, are a component of
all plaque types in all arterial trees and in young and elderly
patients (13), and they have a broad relationship with other
pathology and clinical correlates of CHD risk. The degree
of intimal and adventitial inflammation increases with
increased luminal narrowing (1). Features associated with
culprit lesions, namely plaque area and lipid core area,
correlate positively with macrophage content (25). Virmani
et al. (32) have shown that the degree of macrophage
infiltration is greater in acute plaque rupture than in
thin-cap atheromas or fibrocalcific plaques. Moreno et al.
(66) have shown that the area composed of macrophages
and tissue factor is greater in atherectomy samples from
patients with unstable syndromes versus stable angina. In
human aortic samples, Felton et al. (37) demonstrated that
the plaque area occupied by macrophages is significantly
greater in disrupted plaques than in nondisrupted segments
taken from the same aortas.
The distribution of macrophage infiltration may be as
important as total macrophage content in assessing plaque
vulnerability. Macrophage infiltrates within a thin cap have
been considered an important component of the vulnerable
plaque. In comparison, fatty streaks, or intimal xanthomas,
are rich in macrophages, but they are not rupture-prone
lesions. Surface foam cells overlying an intact fibrous cap,
described to be common in saphenous vein graft atheromas
(67), are also frequent in coronary plaques but are not likely
to be a signal of impending disruption.
Macrophages and monocytes are not the only inflamma-
tory cells in atherosclerotic plaques. The T-cells modulate the
progression of the atherosclerotic plaque by the elaboration of
growth factors and cytokines that affect endothelial cell regu-
lation, smooth muscle cell proliferation, and macrophage
differentiation (68). Neutrophils frequently accompany MPO-
positive macrophages at the site of plaque disruption (33).
Mast cells, which contain neutral proteases and tumor necrosis
factor-alpha, have been implicated as a mechanism of rupture
and have been shown to be located in the shoulder regions.
Could inflammatory plaque imaging identify at-risk pa-
tients? Currently, several methods are under investigation
for detecting intimal macrophages, either using tracers
attached to photodynamic compounds (69), or tracers that
are ingested by surface macrophages and labeled with
magnetic resonance (MR)-sensitive iron (70) or other ra-
diolabeled antibodies directed toward macrophage cell re-
ceptor or matrix metalloproteins. Recently, annexin-based
radionuclide imaging of apoptotic macrophages has been
suggested as a means for identifying plaques prone to
rupture. A study comparing matched segments of athero-
sclerotic plaques from bilateral femoral arteries demon-
strated that, unlike plaque burden and percent lipid core,
inflammation was not distributed homogeneously, suggest-
ing that local identification of inflammation should provide
information as to local vulnerability in excess to that of
systemic factors (71). The heterogeneity of inflammatory
infiltrates within atherosclerotic plaques and the surround-
ing adventitia suggests that imaging techniques developed
for detection of macrophages should embrace other lesion
characteristics, such as lipid pools or biochemical changes,
before assigning an increased risk for vulnerability.
CORRELATION OF RISK FACTORS AND PLAQUE
TYPES, AND RELEVANCE TO SCREENING STRATEGIES
What is the variability of the atherosclerotic process in
clinically relevant subgroups who are candidates for
atherosclerosis imaging? GENDER. The relationships be-
tween traditional risk factors and culprit plaque morphol-
ogy, including plaque rupture and cholesterol, and plaque
erosion and smoking, are similar in both men and women
(27). However, several gender-based differences exist in
plaque morphology. In general, the coronary plaques of
women have been shown to be more cellular than those of
men, possibly because of decreased lipid, especially in the
premenopausal years (28,29). Mean plaque burden and
plaque calcification is less in women up to age 70 who die
with severe coronary atherosclerosis. Plaques of premeno-
pausal women demonstrate relatively little necrotic core and
calcification in comparison to men and postmenopausal
women (30), possibly reflecting the protective effect of
estrogen on the formation of large necrotic cores. The
proportion of fatal atherothrombosis in premenopausal
women that is due to plaque erosion is much higher than in
men (22,27,30). The cause for this relative increase is likely
due to a decrease in the rate of plaque ruptures in this age
group, but population-adjusted rates of fatal plaque erosion are
similar in men and women under the age of 50 years (23).
AGE. A consistent finding in plaque composition is the
relationship between calcified atherosclerosis and age. Gertz
et al. (31) showed that the coronary artery plaques of nonage-
narians are composed primarily of fibrous tissue, suggesting
that the lipid content of plaque decreases with age.
ETHNIC GROUP. Relatively little is known about racial
differences in plaque composition. A recent study (23) has
demonstrated a similar relationship between risk factors and
culprit plaque morphology in blacks and whites, although
the rate of sudden death in blacks dying without acute
thrombus, and in the setting of cardiomegaly, is greater than
in whites. Clinical studies have shown that the calcification
rate of atheromatous plaque is lower in blacks than in
whites, suggesting that screening for calcium in blacks may
not be as sensitive as in whites (72,73).
HYPERCHOLESTEROLEMIA AND DIABETES MELLITUS. Sev-
eral autopsy studies have shown a correlation between
increased serum cholesterol and lipid rich plaques, specifi-
cally thin cap atheromas and plaque rupture (21,23,30), as
well as an association between diabetes and healed plaque
ruptures and plaque with large necrotic cores. A possible
positive correlation exists between calcification and diabetes,
especially in women (5). These data suggest that, in groups
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with specific risk factors, a negative screening test for
lipid-rich or calcified plaques may have a higher predictive
value for the absence of disease than in patients without
these risk factors.
PUTTING IT ALL TOGETHER:
VULNERABLE PLAQUE SCORING SYSTEM?
IS THE SUM GREATER THAN THE PARTS?
It is difficult to prove a substantial incremental value for
imaging atherosclerotic components (above and beyond
assessing plaque burden) in predicting acute coronary
events. The majority of patients with acute coronary events
have two- or three-vessel disease and substantial plaque
burden. However, young patients with premature disease
often have relatively little plaque burden. Furthermore,
imaging of the lumen is not particularly helpful in identi-
fying plaques prone to rupture. Once lesion-targeted inter-
vention is shown to be efficacious, plaque component
imaging will become routine, as is risk factor targeting
today. Another possible benefit of plaque component im-
aging will be the anatomic characterization of coronary
artery atherosclerosis, which is a heterogeneous pathologic
entity. For example, if a patient is identified as having
numerous lipid-rich plaques, approaches to prevent rupture
will form the prevention strategy, whereas if there are few
lipid-rich plaques, prevention of plaque erosion, or strate-
gies to prevent progression of fibrous-rich plaques will be of
paramount concern.
Currently, no vulnerable plaque scoring system is avail-
able for imaging applications. The data reviewed here
suggest that a potential scoring system should include
factors of: 1) fibrous cap thickness, 2) necrotic core size
(both percent of cross sectional plaque area, as well as
length), and 3) degree of macrophage infiltration, either
assessed thermally or by other macrophage localization
methods. It is conceivable in the near future that such a
10-point grading system (three tiers for each feature, and all
negative) could be applied to stratify plaques in regard to
likelihood of future rupture. The degree of positive remod-
eling of expansion of the internal elastic lamina and extent
of vasa vasorum, which has been associated with plaque
instability in the coronary arteries and aortic plaque rupture
(74) and the degree of proliferation of intimal vessels (vasa
vasorum) (75), could also be factored into the scoring system
of vulnerable plaques. Because imaging techniques today
lack the ability to detect of each of the above parameters it
may not be feasible to include all markers of instability into
a scoring system, but one can imagine modifications of such
a scoring scheme as detection techniques improve.
FUTURE DIRECTIONS
1. The science of pathologically defining the characteristics
of vulnerable plaques must be made relevant to the
detection of vulnerable patients. For example, as our
ability improves to image individual components of
atherosclerosis, the accuracy of these determinations
must be measured.
2. Because much of our knowledge on vulnerable plaque is
derived from referred populations within pathology stud-
ies, the applicability of these data to clinical screening
populations must be demonstrated.
3. Tight collaborations between experts in cardiovascular
pathology and clinicians is encouraged to ensure that
proper atherosclerosis “targets” are pursued to improve
the detection of at-risk patients.
4. The development of “vulnerable plaque scoring systems,”
much like considering multiple coronary risk factors in
coronary event prediction, is encouraged.
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Task Force #3—What Is the Spectrum
of Current and Emerging Techniques for the
Noninvasive Measurement of Atherosclerosis?
Rita F. Redberg, MD, MSC, FACC, Co-Chair, Robert A. Vogel, MD, FACC, Co-Chair,
Michael H. Criqui, MD, MPH, David M. Herrington, MD, FACC, Joao A. C. Lima, MD, FACC,
Mary J. Roman, MD, FACC
This task force reviews the technical status and strength of
evidence for the use of carotid ultrasonography, coronary
computed tomography (CT), cardiovascular magnetic reso-
nance imaging (CMR), brachial artery reactivity testing
(BART), and the ankle-brachial index (ABI) in the nonin-
vasive indication of the functional or anatomic manifesta-
tions of atherosclerosis. These methods are either currently
used or have potential for use in the cardiovascular risk
assessment.
The U.S. Preventive Services Task Force recommended
in its 1996 report that any screening test utilized in the
assessment of risk can be considered effective if it: 1)
provides an accurate determination of the likelihood that an
asymptomatic person has the condition (accuracy); 2) if its
results are stable when repeated (reliability); and 3) if early
intervention is likely to have a beneficial impact (1). As an
extension of these concepts, we further recommend that any
imaging method for prediction of cardiovascular risk should
have incremental value to the risk predicted by office-based
risk assessment. This Task Force examined atherosclerosis
imaging from the perspective of accuracy and reliability
of the technologies, whereas the issue of appropriate
intervention and incremental value is more fully dis-
cussed in other Task Force reports of this Bethesda Con-
ference. This Task Force urges the adoption of standard
methodology for each of the imaging methods so that data
can be shared and assessed for quality control measure-
ments. Currently, different protocols and standardization
are used by different laboratories, and it is difficult to
establish normal and abnormal (age and gender adjusted)
values. Also, prior to the widespread adoption of any
imaging technique, it is essential that it be shown to be
reproducible, have low biologic variability, and to be clini-
cally useful. In addition, the Task Force recognizes that
although the literature often refers to test outcomes as
dichotomous for purposes of analysis, the test results of all
of these techniques are actually on a continuous scale.
Consideration of actual results, adjusted for age, gender, and
race, adds valuable information to just a positive or negative
result.
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